Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Delivery
Pharma
Novo snags FDA nod for oral obesity med with Wegovy in a pill
After ringing in a new era of obesity treatment with Wegovy, Novo Nordisk is making history again with the first GLP-1 pill for weight loss.
Fraiser Kansteiner
Dec 22, 2025 6:59pm
Roche's bispecific Lunsumio goes subcutaneous
Dec 22, 2025 10:15am
FDA approves J&J's new challenge to Tagrisso
Dec 18, 2025 10:40am
Halozyme CEO targets new deals as IRA uncertainty subsides
Oct 14, 2025 9:40am
Halozyme buys Elektrofi for up to $900M
Oct 1, 2025 2:36pm
Merck scores FDA approval for subcutaneous Keytruda
Sep 19, 2025 4:54pm
